AVALO THERAPEUTICS, INC. Derivative Liability, Fair Value, Amount Not Offset Against Collateral
AVALO THERAPEUTICS, INC. (AVTX) had Derivative Liability, Fair Value, Amount Not Offset Against Collateral of $100.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral · last filed 2023-11-09
- 2023-09-30: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $100.00K.
- 2023-06-30: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $200.00K.
- 2023-03-31: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $200.00K.
| Period end | Derivative Liability, Fair Value, Amount Not Offset Against Collateral |
|---|---|
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |